Qiming U.s. Healthcare Gp Ii, Llc - Net Worth and Insider Trading

Qiming U.s. Healthcare Gp Ii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Qiming U.s. Healthcare Gp Ii, Llc owns 3 companies in total, including Elevation Oncology Inc (ELEV) , Icosavax Inc (ICVX) , and Jasper Therapeutics Inc (JSPR) .

Click here to see the complete history of Qiming U.s. Healthcare Gp Ii, Llc’s form 4 insider trades.

Insider Ownership Summary of Qiming U.s. Healthcare Gp Ii, Llc

Ticker	Comapny	Transaction Date	Type of Owner
ELEV	Elevation Oncology Inc	2021-06-24	10 percent owner
ICVX	Icosavax Inc	2021-07-28	10 percent owner
JSPR	Jasper Therapeutics Inc	2023-01-27	10 percent owner

Qiming U.s. Healthcare Gp Ii, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Qiming U.s. Healthcare Gp Ii, Llc Ownership Network

Ownership Network List of Qiming U.s. Healthcare Gp Ii, Llc

No Data

Ownership Network Relation of Qiming U.s. Healthcare Gp Ii, Llc

Qiming U.s. Healthcare Gp Ii, Llc Owned Company Details

What does Elevation Oncology Inc do?

Who are the key executives at Elevation Oncology Inc?

Qiming U.s. Healthcare Gp Ii, Llc is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Robert J Adelman , and 10 percent owner Venbio Global Strategic Gp Iii, L.p. .

Elevation Oncology Inc (ELEV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elevation Oncology Inc Insider Transactions

No Available Data

What does Icosavax Inc do?

Who are the key executives at Icosavax Inc?

Qiming U.s. Healthcare Gp Ii, Llc is the 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Medical Officer Niranjan Kanesa-thasan , and Chief Financial Officer Thomas Joseph Russo .

Icosavax Inc (ICVX) Insider Trades Summary

Over the past 18 months, Qiming U.s. Healthcare Gp Ii, Llc made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 193,993 shares made by Adam K. Simpson , a net sale of 28,581 shares made by Cassia Cearley , and a net sale of 36,799 shares made by Douglas Holtzman .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 292,829 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 292,829 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Icosavax Inc Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Qiming U.s. Healthcare Gp Ii, Llc is the 10 percent owner of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Qiming U.s. Healthcare Gp Ii, Llc made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net sale of 11,700 shares made by Jeetinder Singh Mahal , a net purchase of 50,000 shares made by Thomas G Wiggans , and a net sale of 16,465 shares made by William Lis .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 6,854 shares of Jasper Therapeutics Inc (JSPR) were sold and 545,000 shares were bought by its insiders, resulting in a net purchase of 538,146 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

Qiming U.s. Healthcare Gp Ii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Qiming U.s. Healthcare Gp Ii, Llc. You might contact Qiming U.s. Healthcare Gp Ii, Llc via mailing address: 11100 Ne 8th St, Suite 200, Bellevue Wa 98004.

Discussions on Qiming U.s. Healthcare Gp Ii, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.